These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37087486)

  • 1. Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays.
    van Tongeren TCA; Wang S; Carmichael PL; Rietjens IMCM; Li H
    Arch Toxicol; 2023 Jun; 97(6):1547-1575. PubMed ID: 37087486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation risk assessment of human exposure to anti-androgens using newly defined comparator compound values.
    van Tongeren TCA; Moxon TE; Dent MP; Li H; Carmichael PL; Rietjens IMCM
    Toxicol In Vitro; 2021 Jun; 73():105132. PubMed ID: 33662517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.
    Becker RA; Friedman KP; Simon TW; Marty MS; Patlewicz G; Rowlands JC
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):398-408. PubMed ID: 25656492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next Generation Risk Assessment of the Anti-Androgen Flutamide Including the Contribution of Its Active Metabolite Hydroxyflutamide.
    van Tongeren TCA; Carmichael PL; Rietjens IMCM; Li H
    Front Toxicol; 2022; 4():881235. PubMed ID: 35722059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis.
    Wang S; Rijk JC; Besselink HT; Houtman R; Peijnenburg AA; Brouwer A; Rietjens IM; Bovee TF
    Toxicol Sci; 2014 Sep; 141(1):78-89. PubMed ID: 24928889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity.
    Legler J; Zeinstra LM; Schuitemaker F; Lanser PH; Bogerd J; Brouwer A; Vethaak AD; De Voogt P; Murk AJ; Van der Burg B
    Environ Sci Technol; 2002 Oct; 36(20):4410-5. PubMed ID: 12387416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
    Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
    Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards an integrated in vitro strategy for estrogenicity testing.
    Wang S; Aarts JM; de Haan LH; Argyriou D; Peijnenburg AA; Rietjens IM; Bovee TF
    J Appl Toxicol; 2014 Sep; 34(9):1031-40. PubMed ID: 24114741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay.
    Breinholt V; Larsen JC
    Chem Res Toxicol; 1998 Jun; 11(6):622-9. PubMed ID: 9625730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of estrogenic potency in wastewater and surface water with three in vitro bioassays.
    Murk AJ; Legler J; van Lipzig MM; Meerman JH; Belfroid AC; Spenkelink A; van der Burg B; Rijs GB; Vethaak D
    Environ Toxicol Chem; 2002 Jan; 21(1):16-23. PubMed ID: 11808534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect.
    Wang S; Aarts JM; Evers NM; Peijnenburg AA; Rietjens IM; Bovee TF
    J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):98-106. PubMed ID: 22138011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: Total estrogenicity calculations accounting for competitive protein and receptor binding and potency.
    Pande P; Fleck SC; Twaddle NC; Churchwell MI; Doerge DR; Teeguarden JG
    Food Chem Toxicol; 2019 Mar; 125():341-353. PubMed ID: 30553876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combining in vitro estrogenicity data with kinetic characteristics of estrogenic compounds on the in vivo predictive value.
    Punt A; Brand W; Murk AJ; van Wezel AP; Schriks M; Heringa MB
    Toxicol In Vitro; 2013 Feb; 27(1):44-51. PubMed ID: 23036893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employing Dietary Comparators to Perform Risk Assessments for Anti-Androgens Without Using Animal Data.
    Dent MP; Li H; Carmichael PL; Martin FL
    Toxicol Sci; 2019 Feb; 167(2):375-384. PubMed ID: 30247711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and prevalidation of the in vitro ERalpha CALUX method to test estrogenic and antiestrogenic activity of compounds.
    van der Burg B; Winter R; Weimer M; Berckmans P; Suzuki G; Gijsbers L; Jonas A; van der Linden S; Witters H; Aarts J; Legler J; Kopp-Schneider A; Bremer S
    Reprod Toxicol; 2010 Aug; 30(1):73-80. PubMed ID: 20435135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Three ISO Estrogen Receptor Transactivation Assays Applied to 52 Domestic Effluent Samples.
    Simon E; Riegraf C; Schifferli A; Olbrich D; Bucher T; Vermeirssen ELM
    Environ Toxicol Chem; 2022 Oct; 41(10):2512-2526. PubMed ID: 35876436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Generic Physiologically Based Kinetic Model to Predict In Vivo Uterotrophic Responses Induced by Estrogenic Chemicals in Rats Based on In Vitro Bioassays.
    Zhang M; van Ravenzwaay B; Rietjens IMCM
    Toxicol Sci; 2020 Jan; 173(1):19-31. PubMed ID: 31626307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of environmental xeno-estrogens within multi-component mixtures: Comparison of in vitro human- and zebrafish-based estrogenicity bioassays.
    Serra H; Scholze M; Altenburger R; Busch W; Budzinski H; Brion F; Aït-Aïssa S
    Chemosphere; 2019 Jul; 227():334-344. PubMed ID: 30999174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated estrogenicity of native and chemically dispersed crude oil determined using adapted microscale reporter gene assays.
    Johann S; Esser M; Nüßer L; Altin D; Hollert H; Seiler TB
    Environ Int; 2020 Jan; 134():105320. PubMed ID: 31739133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.